Skip to content
Search

Latest Stories

The 'most notable' opportunity for pharmacy owners to capitalise upon in 2024 revealed

The 'most notable' opportunity for pharmacy owners to capitalise upon in 2024 revealed

Overall, pharmacy goodwill prices are anticipated to remain consistent in the coming months 

Pharmacy sales specialist, Hutchings Consultants has revealed its market predictions for the next 12 months in a new report.


The broker is anticipating that both independent group operators and corporate owners will continue to reassess their existing portfolios in 2024, making strategic disposals of varying sizes.

“This is likely to result in transaction volumes remaining high for the foreseeable future,” stated the report authored by Paul Steet, Associate Director, Hutchings Consultants.

Community Pharmacy Contractual Framework negotiations will be the most notable opportunity for the sector to capitalise upon this year, the broker said, adding that it’s “a belated opportunity for the sector to secure a vital uplift to the contract’s fixed global sum.”

The launch of Pharmacy First Scheme in England is seen as a positive development, as Paul said it offers “a much-needed financial boost” to the sector.

He said that the new scheme and the recent announcement of a 5% funding increase in Wales are “already bringing a renewed degree of confidence from buyers as we move into 2024.”

Additionally, the broker has anticipated some reduction in interest rates by the Bank of England in coming months, relieving the financial pressure felt by existing operators to certain extent and assisting buyers with affordability.

Overall, pharmacy goodwill prices are expected to remain consistent during the year unless “the supply of pharmacies on the market falls further or a more significant uplift in community pharmacy funding is secured.”

Hutchings encourages pharmacy owners to focus on their drug buying and profit margin through 2024 as “this is such a key factor for pharmacy goodwill values.”

A look back at 2023

Hallo Healthcare Group’s decision to divest their portfolio of over 1,054 Lloyds Pharmacies resulted in an unprecedented increase in the number of business opportunities on the UK pharmacy market in initial six months of 2023.

The divestment created a “fever-pitch level” of demand from potential buyers both within the market and outside, according to the Hutchings report.

In Scotland alone, Lloyd’s disposals resulted in a massive 533 per cent increase in completed deals at Hutchings.

Although on a significantly smaller scale, Boots and Well also opted to divest some branches, with the former announcing its plan to axe 300 branches around the UK.

Existing pharmacy owners with single branches completed most corporate acquisitions last year, while first-time buyers acquired the majority of the independent sales, according to the broker.

Hutchings saw a significant increase in the number of enquiries and registrations from both new and existing buyers for pharmacy triggered by large-scale corporate disposals in 2023.

In 2023, the number of new buyer registrations increased over 90 per cent, compared to the previous year.

At 77 per cent, first-time buyers accounted for the majority of the new registrations, followed by existing owners at 15 per cent.

Almost all sales the broker transacted last year involved the buyer obtaining a bank loan.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less